Outcomes of peripheral blood stem cell transplantation in patients from human leukocyte antigen matched or mismatched unrelated donors

Tingting CAO; Yanfen LI; Quanshun WANG; Honghua LI; Jian BO; Yu ZHAO; Yu JING; Shuhong WANG; Haiyan ZHU; Liping DOU; Bojun JIA; Chunji GAO; Li YU; Wenrong HUANG.
Chinese Medical Journal ; (24): 2612-2617, 2014.
Artículo en Inglés | WPRIM | ID: wpr-318607

Documentos relacionados

  1. Outcomes of peripheral blood stem cell transplantation in patients from human leukocyte antigen matched or mismatched unrelated donors.
  2. Favorable recovery profiles and good reliability among youngest unrelated stem cell donors supports lowering the minimum donor registration age.
  3. [Peripheral blood stem cell transplantation from HLA-mismatched unrelated donor or haploidentical donor for the treatment of X-linked agammaglobulinemia].
  4. A pyruvate kinase deficiency child with novel PK-LR gene mutations was successfully cured by matched unrelated donor peripheral blood stem cell transplantation.
  5. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
  6. Disability related to chronic graft -<i>versus</i>-host disease after alternative donor hematopoietic cell transplantation.
  7. Partially CD3<sup>+</sup>-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy.
  8. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome.
  9. Comparative study of micro-transplantation from HLA fully mismatched unrelated and partly matched related donors in acute myeloid leukemia.
  10. Total body irradiation-free haploidentical peripheral blood stem cell transplantation compared to related and unrelated donor transplantation in pediatrics with acute lymphoblastic leukemia.